TELA Bio TELA 深 沪
等待开盘 09-17 09:30:00 美东时间
1.58
0.000
0.00%
华盛通- 最 高1.66
- 今 开1.57
- 成交量 13.33万股
- 最 低 1.57
- 昨 收 1.58
- 总市值 6249.69万
- 52周最高 3.26
- 市盈率 静 --
- 换手率 0.34%
- 52周最低 0.8645
- 委 比 93.66%
- 总股本 3955.50万
- 历史最高 23.545
- 量 比 1.91
- 振 幅 5.70%
- 历史最低 0.8645
- 每 手 1
- 风险率 0.66%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多2025 年最受消费者欢迎空气净化器排行榜
当下，空气质量问题愈发受到大众关注，空气净化器已成为众多家庭提升生活品质的必备家电。然而，面对市场上琳琅满目的产品，消费者往往陷入选择困境。为帮助大家选到真正优...
09-16 09:41
Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
08-13 19:10
TELA Bio shares are trading lower after the company reported worse-than-expected Q2 financial results.
TELA Bio shares are trading lower after the company reported worse-than-expecte...
08-12 22:18
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers FibroGen (NASDAQ:FGEN) shares rose 20.1% to $10.11 during Monday's aft...
08-12 05:06
TELA Bio Affirms FY2025 Sales Guidance of $85.000M-$88.000M vs $86.060M Est
TELA Bio (NASDAQ:TELA) affirms FY2025 sales outlook from $85.000 million-$88.000 million to $85.000 million-$88.000 million vs $86.060 million estimate.
08-12 04:49
TELA Bio Q2 EPS $(0.22) Misses $(0.18) Estimate, Sales $20.197M Miss $20.680M Estimate
TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.18) by 20.88 percent. This is a 56.86 percent increase over losses of $(0.51) per share from the
08-12 04:03
Earnings Scheduled For August 11, 2025
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to rep...
08-11 16:32
TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference
TELA Bio, Inc. will participate in the Canaccord Genuity 45th Annual Growth Conference on August 13, 2025, at 10:00 am ET. The company's management will present, and interested parties can access the live or archived webcast via ir.telabio.com. TELA Bio focuses on providing innovative soft-tissue reconstruction solutions. For more information, contact Louisa Smith at ir@telabio.com.
07-23 20:03
TELA Bio to Announce Second Quarter 2025 Financial Results
TELA Bio, Inc. will release its Q2 2025 financial results on August 11, 2025, followed by a conference call and webcast at 4:30 p.m. ET. Interested investors must register in advance. TELA Bio focuses on innovative soft-tissue reconstruction solutions, emphasizing patient anatomy preservation and natural healing. The company is committed to providing effective and economical solutions for surgeons. This press release includes forward-looking stat...
07-21 20:03
